Post-Hysterectomy Pelvic Mass
A pelvic mass found after hysterectomy raises an obvious question: if the uterus has been removed, what is it? The answer depends heavily on what was taken at the original operation, how long ago it was, and why it was performed. Most such findings are benign—ovaries left in place can develop cysts, fluid collections form after surgery, and loops of bowel can settle into the space the uterus once occupied and be mistaken for a mass. A smaller number represent recurrence of the condition that prompted the hysterectomy, or a new problem arising from the ovaries or neighbouring organs. Knowing the surgical history is the single most useful piece of information in sorting these out.
What is it?
Hysterectomy means removal of the uterus, but the term covers several different operations, and understanding which was performed is essential to interpreting any subsequent pelvic finding.
A total hysterectomy removes the uterus and cervix. A subtotal or supracervical hysterectomy removes the body of the uterus but leaves the cervix in place. A radical hysterectomy, performed for cancer, removes the uterus, cervix, surrounding tissue, and upper vagina. Critically, none of these terms says anything about the ovaries. The ovaries are removed only if a salpingo-oophorectomy is performed as well, and in many women—particularly those who were premenopausal at the time—they are deliberately left in place to preserve hormone production.
This is the single most common misunderstanding in this area. Many women believe that hysterectomy removed everything, and are surprised to learn their ovaries remain. An ovary left behind continues to function, continues to ovulate, and continues to form cysts in exactly the way it would have otherwise. A pelvic mass after hysterectomy is therefore frequently nothing more than an ordinary ovarian cyst in a woman who assumed she could no longer have one.
The space the uterus occupied does not remain empty. Bowel, bladder, and surrounding tissue settle into it, and the top of the vagina is closed to form the vaginal vault. This altered anatomy accounts for several benign findings that can be mistaken for a mass.
The causes of a genuine post-hysterectomy pelvic mass fall into recognisable groups.
Ovarian causes are the most common where ovaries were retained. Functional cysts form in premenopausal women as they always did. Benign cysts including dermoid cysts, endometriomas, and cystadenomas occur. Hydrosalpinx—a fluid-filled fallopian tube—can occur where tubes were left, though tubes are now routinely removed at hysterectomy specifically to reduce future ovarian cancer risk.
Ovarian remnant syndrome is an uncommon but important entity. It occurs when a fragment of ovarian tissue is inadvertently left behind during an operation intended to remove the ovaries, usually because dense adhesions from endometriosis, infection, or previous surgery made complete removal difficult. The remnant continues to respond to hormonal signals and can form cysts, producing cyclical pelvic pain in a woman who has been told she has no ovaries and should have none. Blood tests showing premenopausal hormone levels in a woman who should be postmenopausal after oophorectomy are a key clue. It is frequently diagnosed late because the possibility is not considered.
Residual ovary syndrome is different and describes problems arising from an ovary that was deliberately retained—persistent pain, cyst formation, or adhesions involving it.
Postoperative collections are common in the early period. A lymphocele forms where lymph accumulates after lymph node removal, most often after surgery for cancer, and appears as a well-defined fluid collection. Haematomas and seromas form at the vaginal vault or in the pelvis after any hysterectomy. Most resolve spontaneously over weeks to months. An abscess presents with pain, fever, and systemic illness and requires drainage.
Granulation tissue at the vaginal vault is a common cause of bleeding and discharge after hysterectomy. It is benign, appears as a red fleshy area at the surgical scar, and is treated in clinic.
Adhesions and scar tissue form after any pelvic surgery and can create a mass-like appearance, particularly where they bind bowel into a fixed configuration.
Recurrent disease depends on the original indication. Endometriosis can persist or recur after hysterectomy, particularly where ovaries were retained and continue to produce oestrogen, and deposits can form masses. Fibroids do not recur after the uterus is removed, though a retained cervix can occasionally harbour one, and in rare cases a parasitic fibroid—a fragment that acquired its own blood supply, sometimes after morcellation during surgery—can persist and grow.
Malignancy is the concern that drives evaluation. Where hysterectomy was performed for cancer, a new pelvic mass raises the question of recurrence, which most often occurs at the vaginal vault or in pelvic lymph nodes. Where ovaries were retained, ovarian cancer remains possible and the risk is unchanged by hysterectomy. Where the cervix was retained in a subtotal hysterectomy, cervical cancer remains possible, which is why cervical screening must continue in these women—a point frequently missed. Cancers of neighbouring organs, including bowel and bladder, can present as a pelvic mass.
Non-gynaecological causes should not be forgotten. A pelvic kidney, bowel pathology including diverticular disease or tumour, bladder abnormalities, and nerve sheath tumours all occur in this space.
Symptoms vary and are frequently absent.
Where present, pelvic pain or pressure is most common. A cyclical pattern—pain that recurs monthly despite the absence of periods—is a particularly useful clue, pointing toward retained ovarian tissue, an ovarian remnant, or endometriosis responding to continuing hormonal cycles.
A palpable mass, abdominal distension, urinary symptoms from pressure on the bladder, and bowel symptoms all occur with larger lesions.
Vaginal bleeding or blood-stained discharge after hysterectomy always warrants assessment. There is no menstrual source, so any bleeding has another explanation—most often granulation tissue or vaginal atrophy, but recurrence at the vault must be excluded. This is the symptom most likely to be dismissed and most important not to ignore.
Unexplained weight loss, persistent bloating, early satiety, and new abdominal swelling warrant prompt evaluation, since these are the symptoms associated with ovarian and peritoneal malignancy.
Assessment begins with a piece of information that is often harder to obtain than it should be: what exactly was removed. The operation record specifies whether ovaries and tubes were taken, whether the cervix was retained, the indication, and the findings. A woman may genuinely not know, and assumptions in either direction cause problems. Obtaining this record changes the differential diagnosis more than any test.
Transvaginal ultrasound remains the first-line investigation and works well after hysterectomy. It assesses the vaginal vault, locates and characterises the ovaries if present, and evaluates any mass. A practical caution applies: loops of bowel settling into the space where the uterus sat are a recognised source of false impressions, and fluid-filled bowel in particular can resemble a cystic mass. Watching for peristalsis and reassessing after an interval usually resolves this.
MRI of the pelvis gives the clearest characterisation and is particularly valuable for distinguishing recurrent disease from postoperative fibrosis, which can look similar on other tests. It is the investigation of choice where ultrasound is inconclusive.
CT assesses the wider abdomen, identifies lymph node enlargement, and is used in staging.
PET-CT helps distinguish metabolically active recurrent disease from inert scar tissue in women previously treated for cancer, a distinction that is often otherwise difficult.
Blood tests contribute selectively. In suspected ovarian remnant syndrome, hormone levels showing premenopausal function in a woman who should be postmenopausal support the diagnosis, and stimulation testing is used in some centres. Tumour markers including CA-125 are interpreted cautiously, since they are elevated in endometriosis, inflammation, and after recent surgery as well as in malignancy.
Biopsy or surgical assessment provides the diagnosis where imaging leaves the question open and the answer would change management.
Important to Know
The most useful first step for any woman found to have a pelvic mass after hysterectomy is establishing what was removed at the original operation, since this determines what the finding can plausibly be. Care is typically coordinated by gynaecologists, with gynaecological oncology involvement where the original surgery was for cancer or where malignancy is suspected.
Most findings are benign and many require no treatment. A simple ovarian cyst in a woman with retained ovaries is managed exactly as it would be in any woman—by its size, appearance, and symptoms rather than by the fact of previous hysterectomy. Small postoperative collections resolve on their own and need only reassurance and, where appropriate, a follow-up scan to confirm resolution.
Several specific points are worth understanding.
Retained ovaries continue to function. Women who assumed hysterectomy ended all gynaecological possibility are frequently surprised to find they can develop ovarian cysts, experience cyclical pelvic pain or premenstrual symptoms without bleeding, and remain at risk of ovarian cancer. This is not a complication of the surgery but a consequence of what was deliberately preserved.
Cervical screening must continue after subtotal hysterectomy, where the cervix was retained. This is a recognised gap in care—women are often removed from screening programmes after any hysterectomy without the record being checked. Women who have had hysterectomy for cervical precancer or cancer also require ongoing vault screening even where the cervix was removed. Checking which operation was performed and whether screening should continue is worth doing actively rather than assuming.
Ovarian remnant syndrome deserves specific consideration in any woman with cyclical pelvic pain after an operation intended to remove both ovaries, particularly where the surgery was complicated by adhesions or endometriosis. It is frequently missed because the possibility seems anatomically impossible. Treatment is surgical excision of the remnant, which is technically demanding and best performed by a surgeon experienced with difficult pelvic anatomy.
Any vaginal bleeding after hysterectomy requires assessment. Granulation tissue at the vault is the most common explanation and is easily treated, but recurrence must be excluded, particularly where hysterectomy was performed for cancer.
Endometriosis can persist after hysterectomy, and this surprises many women who were told the operation would cure it. Where ovaries are retained, continuing oestrogen production can sustain deposits. Even after removal of the ovaries, residual disease can occasionally be stimulated by hormone replacement therapy, and this is worth knowing if symptoms persist or return.
For women treated for cancer, a new mass is assessed as potential recurrence until characterised. Most gynaecological cancer recurrence after hysterectomy occurs at the vaginal vault or in pelvic nodes, and treatment depends on site, extent, previous treatment, and time since the original diagnosis—isolated vault recurrence after surgery alone can often still be treated with curative intent.
A note about anxiety is appropriate. Finding a pelvic mass after hysterectomy can be particularly frightening, both because women assume the possibility was removed with the uterus and because for those treated for cancer it immediately raises the question of recurrence. The majority of such findings have benign explanations, and establishing the diagnosis is usually straightforward with the right information and imaging.
Care is coordinated by gynaecology, with gynaecological oncology, radiology, and colorectal or urological input as the picture requires. Imaging and clinical findings are interpreted alongside the operative record, the original indication, menopausal and hormonal status, and time since surgery rather than in isolation.
Patient education plays an important role. Understanding that hysterectomy does not necessarily mean the ovaries were removed, that retained ovaries behave normally including forming cysts, that cervical screening may still be required, that any vaginal bleeding warrants assessment, and that most masses found in this situation are benign all contribute to appropriate care.
Red flag symptoms include any vaginal bleeding or blood-stained discharge after hysterectomy; a rapidly enlarging pelvic or abdominal mass; persistent bloating, abdominal swelling, or early satiety; unexplained weight loss; new or worsening pelvic pain, particularly if constant rather than cyclical; new leg swelling; difficulty passing urine or a change in bowel habit; fever with pelvic pain, suggesting an abscess; and any new symptom in a woman whose hysterectomy was performed for cancer. These warrant prompt medical evaluation.